Zyban (Bupropion) – give up smoking!
Zyban (Bupropion) is a non-typical antidepressant. The medicine is intended for all those who decided to cease smoking. Though Zyban (Bupropion) does not contain nicotine, it could be successfully used in smoking cessation therapy. The medicine works by reducing the severity of smoking cessation symptoms. In Great Britain more than 500 thousand patients with nicotine dependence has already used it. Zyban showed itself as a safe and effective medicine. This has been proved by a long-term clinical use for treating depression in Canada and the USA. In the USA Zyban (Bupropion) was registered back in 1989 initially as a medicine for treating depression. Since that time 28 million patients in the whole world have used it (20 million for treating various forms of depression and 8 million – against nicotine dependence). Smoking is a risk factor for most chronic diseases, especially cardiovascular dysfunctions. With time smoking tobacco forms an addictive behavior. 90% of smokers are willing to give up smoking; just 3–5% manage to do that. That is why aiding the smokers to overcome nicotine dependence and give up smoking is an important practical task to be solved by healthcare professionals. Presently nicotine dependence is considered as a disease. An important role in relief of nicotine dependence symptoms plays pharmaceutical means, and Zyban (Bupropion) takes the lead among them.